Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PRECIPIO INC. DL-,001
No Price
01.05.2026 20:16
Current Prices from PRECIPIO INC. DL-,001
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
PRPO
USD
01.05.2026 20:16
30,94 USD
0,04 USD
+0,13 %
IEX
PRPO
USD
01.05.2026 19:59
30,80 USD
-0,10 USD
-0,34 %
Share Float & Liquidity
Free Float81,10 %
Shares Float1,45 M
Shares Outstanding1,78 M
Company Profile for PRECIPIO INC. DL-,001 Share
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
